Sagimet Biosciences Inc.
Status: Publicly traded
Direct answer
Sagimet Biosciences Inc. is publicly traded on NASDAQ under the ticker SGMT.
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States. The company’s lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated...
Can you invest in Sagimet Biosciences Inc.?
Yes. Sagimet Biosciences Inc. trades publicly on NASDAQ as SGMT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Sagimet Biosciences Inc.
Detailed equity research is provided by MarketSnap.